Home » Health Care

Press Releases

BIO Submits Comments on FDA Draft Guidances on Biosimilars
April 17 2012

The Biotechnology Industry Organization (BIO) submitted comments yesterday to the U.S. Food...

BIO Testifies on Importance of Timely Passage of BsUFA and PDUFA
March 29 2012

Sara Radcliffe, Executive Vice President of Health at the Biotechnology Industry Organization...

TREAT Act Offers Renewed Hope for Patients
February 15 2012

The bill will modernize the FDA and accelerate patient access to cures and new treatments.

Release of FDA Guidance for Biosimilars Pathway Marks Important Step Forward, Says BIO
February 9 2012

BIO President and CEO Jim Greenwood issued the following statement regarding the newly...

Representative Upton Honored as BIO Legislator of the Year
May 4 2011

BIO announces selection of Congressman Fred Upton (R-MI) as Legislator of the Year for 2010 -...

Congressman Price Honored as BIO Legislator of the Year
May 4 2011

The Biotechnology Industry Organization (BIO) announced today its selection of Representative...

Representative Capuano Honored as BIO Legislator of the Year
May 4 2011

The Biotechnology Industry Organization (BIO) announced today its selection of Congressman...

Final Biosimilars Pathway Must Make Patient Safety and Incentives For Continued Innovation Top Priorities, Says BIO
November 3 2010
New BIO Report Highlights Value of Biotechnology to Individuals and Society
May 4 2010

A new report issued by the Biotechnology Industry Organization underscores how biotechnology...

Letters, Testimony & Comments

Biosimilars: BIO Comments on FDA's Biosimilars User Fee Cover Sheet
May 14 2012
Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to...
FDA Public Meeting: Approval Pathway for Biosimilar and Interchangeable Biological Products
May 11 2012
Sara Radcliffe, executive vice president of health for BIO, presented at a Food and Drug Administration public hearing on the approval...
Biosimilars: BIO Comments on Questions and Answers Regarding Implementation of BPCIA
April 16 2012
The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on the...
Biosimilars: BIO Comments on Quality Considerations
April 16 2012
The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on the...
Biosimilars: BIO Comments on Scientific Considerations
April 16 2012
The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on the...
More Letters, Testimony & Comments →

Press Releases

BIO Submits Comments on FDA Draft Guidances on Biosimilars
April 17 2012
Washington, D.C. (April 17, 2012) – The Biotechnology Industry Organization (BIO) submitted comments yesterday...
BIO Testifies on Importance of Timely Passage of BsUFA and PDUFA
March 29 2012
Washington, D.C. (March 29, 2012) – Sara Radcliffe, Executive Vice President of Health at the Biotechnology...
TREAT Act Offers Renewed Hope for Patients
February 15 2012
Washington, DC (February 15, 2012) – Today, the Biotechnology Industry Organization (BIO) praised Sen. Kay...
Release of FDA Guidance for Biosimilars Pathway Marks Important Step Forward, Says BIO
February 9 2012
Patient Safety Must Remain Top Priority Washington, D.C. (February 9, 2012) — Biotechnology Industry...
Representative Upton Honored as BIO Legislator of the Year
May 4 2011
WASHINGTON, D.C. (Tuesday, May 04, 2011) - The Biotechnology Industry Organization (BIO) announced today its...
More Press Releases →